Abstract Globally, Hepatitis E virus (HEV) causes over 20 million cases worldwide. HEV is
an emerging and endemic pathogen within economically developed countries, chiefly …

Background and Aims Hepatitis E virus (HEV) variants causing human infection
predominantly belong to HEV species A (HEV‐A). HEV species C genotype 1 (HEV‐C1) …

Hepatitis E virus infection can cause chronic hepatitis in immunocompromised patients with
significant chance of progressive fibrosis and possibly cirrhosis. The aim of this systematic …

Background and objectives COVID‐19 convalescent plasma (CCP) has been used,
predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest …

We investigated the seasonal prevalence of seven enteric viruses in groundwater-derived
public water sources distributed across the dominant aquifers of England. Sampling targeted …

Abstract Background/Aims Hepatitis E virus (HEV) infection is an important cause of acute
viral hepatitis worldwide, but it is long‐neglected. We aimed to understand the global trends …

ABSTRACT HEV-Ag ELISA assay is a reliable diagnostic test in resource-limited areas. HEV
genotype 1 (HEV-1) infections are either self-limited or progress to fulminant hepatic failure …

Introduction In low-income countries, Hepatitis E infection is a common cause of acute
hepatitis. So far, only two recombinant vaccines (rHEV and HEV 239) have been developed …

Purpose Hepatitis E virus (HEV) causes acute hepatitis in humans and constitutes a major
problem for immunocompromised patients, patients with hematological diseases, and …

Abstract Background Hepatitis E virus (HEV) is a nonenveloped RNA virus causing hepatitis
E worldwide. The increase in transfusion-transmitted cases of HEV infections from …